NovaSure impedance controlled system for endometrial ablation: The experience of the first UK reference centre

Summary In this study we assessed the effectiveness of the NovaSure Impedance Controlled Endometrial Ablation System for the treatment of menorrhagia in pre-menopausal women. A total of 125 pre-menopausal women with menorrhagia, which was secondary to dysfunctional uterine bleeding and unresponsive to medical therapy, had endometrial ablation using the NovaSure system between June 2004 and October 2005. A postal questionnaire was sent to all patients and the response rate was 80% (110 patients). The clinical data were analysed in 105 case notes (84%). The mean age was 43.91 ± 5.45 SD, and mean parity was 2.09 ± 0.65. The median treatment time was 71.00 s, ranging between 45.00 and 105.00 s. Results from a period of 18 months demonstrated that the NovaSure system was effective in reducing excessive uterine blood loss in 90.5% of patients and there were no intraoperative adverse events reported. Some 87% of patients were satisfied with the procedure and 90% of patients would be happy to recommend the treatment. We conclude that the NovaSure system is effective and safe in the treatment of symptomatic menorrhagia.